Clarus Therapeutics Announces Notice of Allowance for Additional Patent Claims Covering JATENZO® (testosterone undecanoate)
July 28, 2022 09:05 ET
|
Clarus Therapeutics Holdings, Inc.
JATENZO is the first and only FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions NORTHBROOK, Ill., July ...
ZetrOZ Systems Shares Successful Strategies for Managing a Robust Intellectual Property Portfolio
July 18, 2022 10:31 ET
|
ZetrOZ Systems
TRUMBULL, Conn., July 18, 2022 (GLOBE NEWSWIRE) -- Running a successful medical device company requires deep knowledge of complex and specialized technologies, how to navigate regulatory...
Lightbridge Receives Notice of Allowance on Key Patent from the Canadian Intellectual Property Office
July 13, 2022 08:00 ET
|
Lightbridge Corporation
RESTON, Va., July 13, 2022 (GLOBE NEWSWIRE) -- Lightbridge Corporation (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that it has received a Notice of Allowance from...
Algernon Pharmaceuticals Discloses Novel DMT Salt Patent Strategy Includes Bioactive Nicotinate and Pamoate
July 05, 2022 07:00 ET
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, July 05, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage pharmaceutical...
Digital Ally Announces Three 2022 Patents
June 28, 2022 09:00 ET
|
Digital Ally Inc.
Patents are for vital hardware and software enhancements for evidence capture and safety technology Lenexa, KS, June 28, 2022 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (NASDAQ: DGLY) (the...
AST Announces Results for IP3 2021 - Collaborative Patent Purchase Program
June 28, 2022 09:00 ET
|
Allied Security Trust
PRINCETON, N.J., June 28, 2022 (GLOBE NEWSWIRE) -- AST, the Member-driven leading provider of proactive and collaborative patent defense solutions, today announced the 2021 results of its sixth...
Algernon Pharmaceuticals Announces Issuance of Patent for Ifenprodil for the Treatment of Idiopathic Pulmonary Fibrosis
June 22, 2022 07:00 ET
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, June 22, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGWO) (OTCQB: AGNPF), a Canadian clinical stage...
アナクアが特許法律事務所向け知財管理ソリューションの拡充に Practice Insightを買収
June 22, 2022 03:00 ET
|
Anaqua
ボストン, June 22, 2022 (GLOBE NEWSWIRE) -- 知的財産管理そして発明管理ソリューションの大手テクノロジープロバイダーであるアナクア社（Anaqua）は、Practice Insight Pty LtdそしてそのタイムキャプチャーソフトウエアであるWiseTimeをIPH Limitedから買収する最終契約を締結したことを発表しました。 Practice...
Anaqua annonce l'acquisition de Practice Insight pour compléter ses solutions de gestion de la PI à destination des cabinets d'avocats
June 22, 2022 03:00 ET
|
Anaqua
BOSTON, 22 juin 2022 (GLOBE NEWSWIRE) -- Anaqua, leader mondial de l'innovation et de la gestion de la propriété intellectuelle (PI), annonce aujourd'hui la conclusion d'un accord définitif pour...
Anaqua to Acquire Practice Insight to Round Out its Law Firm IP Management Solutions
June 22, 2022 03:00 ET
|
Anaqua
BOSTON, June 22, 2022 (GLOBE NEWSWIRE) -- Anaqua, the leading global innovation and intellectual property (IP) management technology provider, today announced that it has entered into a definitive...